
Svl Pathology And Allergy Research Centr
Founded in 2019 and headquartered in Punjab, India.
Founded in 2019 and headquartered in Punjab, India.
Patiala, Punjab, India
+91-XXXXXXXXXX
AAO-0561
16 Jan 2019
-
Roc-Chandigarh
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shiv Garg ![]() | Designated Partner | 16-Jan-2019 | Current |
Vivek Bansal ![]() | Designated Partner | 16-Jan-2019 | Current |
Enhance accessibility to Svl Pathology And Allergy Research Centr's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Svl Pathology And Allergy Research Centr's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Shiv Garg is a mutual person
₹0
₹1.53 M
Date | Lender | Amount | Status |
---|---|---|---|
20 Mar 2019 | Siemens Financial Services Private Limited | ₹1.53 M | Satisfied |
Unlock and access historical data on people associated with Svl Pathology And Allergy Research Centr, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Svl Pathology And Allergy Research Centr, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svl Pathology And Allergy Research Centr's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 20 Mar 2019 via Charge ID 100259985 with Siemens Financial Services Private Limited was fully satisfied on 29 Sep 2021.
A charge with Siemens Financial Services Private Limited amounted to Rs. 1.53 M with Charge ID 100259985 was registered on 20 Mar 2019.
Shiv Bhagwan Garg was appointed as a Designated Partner was appointed as a Designated Partner on 16 Jan 2019 & has been associated with this company since 6 years 4 months .
Vivek Bansal was appointed as a Designated Partner was appointed as a Designated Partner on 16 Jan 2019 & has been associated with this company since 6 years 4 months .
Svl Pathology And Allergy Research Centr was registered on 16 Jan 2019 with RoC-Chandigarh & aged 6 years 4 months as per MCA records.
Svl Pathology And Allergy Research Centr was incorporated on 16 Jan 2019.
The Obligation of Contribution of Svl Pathology And Allergy Research Centr is ₹ 0.10 M.
Currently 2 partners are associated with Svl Pathology And Allergy Research Centr.
As per Ministry of Corporate Affairs (Mca), the registered address of Svl Pathology And Allergy Research Centr is Scf 21 Ground Floor Hollywood Plaza Vip Road, Zirakpur, Patiala, Punjab, India, 140603.
The Limited Liability Partnership Identification Number (LLPIN) of Svl Pathology And Allergy Research Centr is AAO-0561.
Search company & director profiles for free and gain access to critical business data.